https://www.selleckchem.com/products/jte-013.html
5). There was no difference in mean ∆WOMAC scores (PAD=39, CON=41; p=0.9) or ∆KOOS subscales between groups. In addition, there were no differences in complications or reoperations between groups. PAD was not superior to CON in improving patient-reported outcomes or reducing complications and reoperation rates at medium term follow-up. The use of PAD in TKA to improve clinical outcomes alone cannot be justified based on the results of this study. PAD was not superior to CON in improving patient-reported outcomes or reducing complication
Like
Comment
Share
